Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00276510
Show Display Options
Rank Status Study
1 Completed A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints
Conditions: Memory Disorders, Age-Related;   Retention Disorders, Cognitive
Interventions: Drug: EGb 761® (Tanakan®);   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.